Dr Antony Mersiades

Dr Antony Mersiades is an accomplished and highly skilled Medical Oncologist specialising in the treatment of lung cancers, gastrointestinal cancers, and cancer research. With his extensive experience in the field, Dr. Mersiades has become adept at diagnosing and treating advanced cancers, utilizing innovative techniques and cutting-edge treatments.

Currently serving as an oncology research fellow at the NHMRC Clinical Trials Centre at the University of Sydney, Dr. Mersiades is actively involved in various clinical trials at Northern Beaches Hospital. His pivotal role in testing and evaluating different drugs and treatments has led to significant breakthroughs and saved countless lives.

Dr. Mersiades exhibits unwavering commitment and dedication to his work, consistently pushing the boundaries to improve cancer treatments. Recently completing a Master of Medicine in Clinical Epidemiology, he has honed his skills in research methodology and evidence-based medicine, enabling him to contribute significantly to the Thoracic Oncology Group of Australasia clinical trial program. Through this program, he has gained invaluable practical experience in trial design, implementation, monitoring, and analysis.

Dr. Antony Mersiades' relentless pursuit of advancements in cancer treatment has earned him recognition and accolades. He has published articles in prestigious medical journals, such as the Medical Journal of Australia and BMJ Open, focusing on medicinal cannabis and its effectiveness in managing chemotherapy-induced nausea and vomiting.

In summary, Dr. Antony Mersiades is a passionate and devoted medical professional whose expertise has made a significant impact on cancer research. Through his unwavering commitment, extensive knowledge, and dedication to his patients, he continues to enhance the quality of life for cancer patients. Dr. Mersiades' groundbreaking work in the field has opened up new possibilities and set a benchmark for the treatment of lung cancers, gastrointestinal cancers, and cancer research as a whole.